跳至主要内容
临床试验/DRKS00016760
DRKS00016760已完成不适用

Post-market clinical follow-up (PMCF) study to investigate the percentage of relapses in treatment with KadeFungin® Milchsäurekur and its tolerability in female patients suffering from recurrent urinary tract infection - PANAMA

DR. KADE Pharmazeutische Fabrik GmbH0 个研究点目标入组 81 人开始时间: 2019年2月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
81

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • Signed informed consent form (ICF) and data privacy statement
  • - Female patients aged =18 years with recurrent acute uncomplicated urinary tract infection (rUTI): = 2 UTIs within the last 6 months or = 3 UTIs within the last 12 months

排除标准

  • Patients with known hypersensitivity to any of the ingredients of KadeFungin® Milchsäurekur

研究者

相似试验